Adaptimmune Annual report pursuant to Section 13 and 15(d)

Income taxes - Components of Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
United States:
Federal	$ 162	$ 242	$ 400
State and local			97
Total current tax expense	162	242	497
United States:
Total income tax expense (benefit)	$ 162	$ 242	$ 497

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.